These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 3520078)
1. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078 [TBL] [Abstract][Full Text] [Related]
2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture. Johnston WW Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301 [TBL] [Abstract][Full Text] [Related]
3. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3. Johnston WW; Szpak CA; Thor A; Schlom J Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920 [TBL] [Abstract][Full Text] [Related]
5. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Friedman EL; Hayes DF; Kufe DW Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas. Katari RS; Fernsten PD; Schlom J Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152 [TBL] [Abstract][Full Text] [Related]
7. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies. Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against human ovarian tumor-associated antigens. Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452 [TBL] [Abstract][Full Text] [Related]
9. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Molinolo A; Simpson JF; Thor A; Schlom J Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774 [TBL] [Abstract][Full Text] [Related]
10. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145 [TBL] [Abstract][Full Text] [Related]
11. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620 [TBL] [Abstract][Full Text] [Related]
12. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas. Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547 [TBL] [Abstract][Full Text] [Related]
13. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375 [TBL] [Abstract][Full Text] [Related]
14. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527 [TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010 [TBL] [Abstract][Full Text] [Related]
16. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies. Simpson J; Schlom J Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701 [TBL] [Abstract][Full Text] [Related]
17. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3. Roa RA; Hruban RH; McKenzie P; Richtsmeier W Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187 [TBL] [Abstract][Full Text] [Related]
19. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3. Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721 [TBL] [Abstract][Full Text] [Related]
20. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Sheer DG; Schlom J; Cooper HL Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]